Micar Innovation Competitors and Similar CompaniesClear all
Micar Innovation's competitors and similar companies include Ankrin Therapeutics, HitGen and Amgen.
 Micar Innovation Micar Innovation is a company developing therapies to treat unmet and rare genetic diseases. |  HitGen HitGen (成都先导药物开发股份有限公司) is a biotech company providing a platform for small molecule drug discovery research. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 | Founding Date 2012 | Founding Date 1980 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Sofia, BG HQ Sofia, BG | Locations København, DK HQ | Locations Chengdu, CN HQ Cambridge, GB | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more |
Employees | Employees 4 | Employees 5 | Employees 483 | Employees 25,200 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥523.7m (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥240.6m (FY, 2025) | Cost of goods $12b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥283.3m (FY, 2025) | Gross profit $24.7b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ¥110.1m (FY, 2025) | Net income $7.7b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Ankrin Therapeutics
HQ
København, DK
Employees
5
Ankrin Therapeutics is s company developing drugs for cancer treatment.
View companyHitGen
HQ
Chengdu, CN
Employees
483
HitGen (成都先导药物开发股份有限公司) is a biotech company providing a platform for small molecule drug discovery research.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company